A widening longevity gap between people with schizophrenia and general population: A literature review and call for action

Schizophrenia Research

Volumn 196, Issue , 2018, Pages 9-13

  Lee, Ellen E ^a,b   Liu, Jinyuan ^a   Tu, Xin ^a   Palmer, Barton W ^a,c   Eyler, Lisa T ^a,c   Jeste, Dilip V ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California San Diego School of Medicine   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heart disease; Mortality; Obesity; Psychotic disorders; Schizophrenia

Indexed keywords

ARTICLE; DEVELOPED COUNTRY; HEALTH CARE; HEART DISEASE; HUMAN; LIFESPAN; LONGEVITY; LONGITUDINAL STUDY; MORTALITY RATE; OBESITY; POLICY; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SOCIAL STIGMA; SOCIOECONOMICS; STANDARDIZATION; SYSTEMATIC REVIEW; MORTALITY;

HUMANS; LONGEVITY; SCHIZOPHRENIA;

EID: 85030691025     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2017.09.005     Document Type: Article

References (46)

1. Abdoli, G., Bottai, M., Sidorchuk, A., et al. Trends in mortality after cancer diagnosis: a nationwide cohort study over 45 years of follow-up in Sweden by country of birth. Cancer Epidemiol. 39 (2015), 633–640.
2. Aizer, A.A., Wilhite, T.J., Chen, M.H., et al. Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer 120 (2014), 1532–1539.
3. Autier, P., Boniol, M., Gavin, A., et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ, 343, 2011, d4411.
4. Brook, O.H., Mortality in the long-stay population of Dutch mental hospitals. Acta Psychiatr. Scand. 71:6 (1985), 626–635.
5. Brown, S., Excess mortality of schizophrenia. A meta-analysis. Br. J. Psychiatry 171 (1997), 502–508.
6. Brown, S., Kim, M., Mitchell, C., Inskip, H., Twenty-five year mortality of a community cohort with schizophrenia. Br. J. Psychiatry 196:2 (2010), 116–121.
7. Capasso, R.M., Lineberry, T.W., Bostwick, J.M., et al. Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950–2005. Schizophr. Res. 98 (2008), 287–294.
8. Chetty, R., Stepner, M., Abraham, S., et al. The association between income and life expectancy in the United States, 2001–2014. JAMA 315 (2016), 1750–1766.
9. Craig, T.J., Lin, S.P., Death and deinstitutionalization. Am. J. Psychiatry 138 (1981), 224–227.
10. Eyawo, O., Franco-Villalobos, C., Hull, M.W., et al. Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012. BMC Infect. Dis., 17, 2017, 174.
11. Giel, R., Dijk, S., van Weerden-Dijkstra, J.R., Mortality in the long-stay population of all Dutch mental hospitals. Acta Psychiatr. Scand. 57:5 (1978), 361–368.
12. Goldman, H.H., Mental illness and family burden: a public health perspective. Hosp. Community Psychiatry 33 (1982), 557–560.
13. Hartley, A., Marshall, D.C., Salciccioli, J.D., et al. Trends in mortality from ischemic heart disease and cerebrovascular disease in Europe: 1980 to 2009. Circulation 133 (2016), 1916–1926.
14. Haugland, G., Craig, T.J., Goodman, A.B., et al. Mortality in the era of deinstitutionalization. Am. J. Psychiatry 140 (1983), 848–852.
15. Hennekens, C.H., Hennekens, A.R., Hollar, D., et al. Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 150 (2005), 1115–1121.
16. Hoang, U., Stewart, R., Goldacre, M.J., Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999–2006. BMJ, 343, 2011, d5422.
17. Høye, A., Jacobsen, B.K., Hansen, V., Increasing mortality in schizophrenia: are women at particular risk? A follow-up of 1111 patients admitted during 1980–2006 in Northern Norway. Schizophr. Res. 132:2-3 (2011), 228–232.
18. Jakobsen, E., Rasmussen, T.R., Green, A., Mortality and survival of lung cancer in Denmark: results from the Danish Lung Cancer Group 2000–2012. Acta Oncol. 55:Suppl. 2 (2016), 2–9.
19. Jeste, D.V., Wolkowitz, O.M., Palmer, B.W., Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophr. Bull. 37 (2011), 451–455.
20. Jin, H., Shih, P.A., Golshan, S., et al. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. J. Clin. Psychiatry 74 (2013), 10–18.
21. Kirkpatrick, B., Messias, E., Harvey, P.D., et al. Is schizophrenia a syndrome of accelerated aging?. Schizophr. Bull. 34 (2008), 1024–1032.
22. Lamb, H.R., Bachrach, L.L., Some perspectives on deinstitutionalization. Psychiatr. Serv. 52 (2001), 1039–1045.
23. Laursen, T.M., Nordentoft, M., Heart disease treatment and mortality in schizophrenia and bipolar disorder - changes in the Danish population between 1994 and 2006. J. Psychiatr. Res. 45 (2011), 29–35.
24. Laursen, T.M., Munk-Olsen, T., Vestergaard, M., Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr. Opin. Psychiatry 25 (2012), 83–88.
25. Laursen, T.M., Nordentoft, M., Mortensen, P.B., Excess early mortality in schizophrenia. Annu. Rev. Clin. Psychol. 10 (2014), 425–448.
26. Leff, J., Thornicroft, G., Coxhead, N., et al. The TAPS Project. 22: a five-year follow-up of long-stay psychiatric patients discharged to the community. Br. J. Psychiatry Suppl., 1994, 13–17.
27. Lesage, A.D., Trapani, V., Tansella, M., Excess mortality by natural causes of Italian schizophrenic patients. Eur. Arch. Psychiatry Neurol. Sci. 239 (1990), 361–365.
28. Licht, R.W., Mortensen, P.B., Gouliaev, G., et al. Mortality in Danish psychiatric long-stay patients, 1972–1982. Acta Psychiatr. Scand. 87 (1993), 336–341.
29. Marder, S.R., Essock, S.M., Miller, A.L., et al. Physical health monitoring of patients with schizophrenia. Am. J. Psychiatry 161 (2004), 1334–1349.
30. Meyer, J.M., Nasrallah, H.A., McEvoy, J.P., et al. The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) schizophrenia trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr. Res. 80 (2005), 9–18.
31. Mortensen, P.B., Juel, K., Mortality and causes of death in schizophrenic patients in Denmark. Acta Psychiatr. Scand. 81 (1990), 372–377.
32. Munk-Jorgensen, P., Mortensen, P.B., Incidence and other aspects of the epidemiology of schizophrenia in Denmark, 1971–87. Br. J. Psychiatry 161 (1992), 489–495.
33. Nielsen, R.E., Uggerby, A.S., Jensen, S.O., et al. Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades–a Danish nationwide study from 1980 to 2010. Schizophr. Res. 146 (2013), 22–27.
34. Olfson, M., Gerhard, T., Huang, C., et al. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 72 (2015), 1172–1181.
35. Olson, R.P., (eds.) Mental Health Systems Compared, 2006, Charles C. Thomas Publisher, Great Britain, Norway, Canada and the United States. Springfield, IL.
36. Osby, U., Correia, N., Brandt, L., Ekbom, A., Sparen, P, Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study. BMJ 321:7259 (2000), 483–484.
37. Rahimi, K., Duncan, M., Pitcher, A., et al. Mortality from heart failure, acute myocardial infarction and other ischaemic heart disease in England and Oxford: a trend study of multiple-cause-coded death certification. J. Epidemiol. Community Health 69 (2015), 1000–1005.
38. Saha, S., Chant, D., McGrath, J., A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch. Gen. Psychiatry 64 (2007), 1123–1131.
39. Saugstad, L., Odegard, O., Recent rise in supposedly stress dependent causes of death in psychiatric hospitals in Norway indicating increased “stress” in hospitals?. Acta Psychiatr. Scand. 71:4 (1985), 402–409.
40. Sloan, F.A., Ayyagari, P., Salm, M., et al. The longevity gap between Black and White men in the United States at the beginning and end of the 20th century. Am. J. Public Health 100 (2010), 357–363.
41. Stroup, D.F., Berlin, J.A., Morton, S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000), 2008–2012.
42. Torniainen, M., Mittendorfer-Rutz, E., Tanskanen, A., et al. Antipsychotic treatment and mortality in schizophrenia. Schizophr. Bull. 41 (2015), 656–663.
43. Tsai, J., Stroup, T.S., Rosenheck, R., Housing arrangements among a national sample of adults with chronic schizophrenia living in the United States: a descriptive study. J. Community Psychol., 2011, 76–88.
44. Tsuang, M.T., Woolson, R.F., Mortality in patients with schizophrenia, mania, depression and surgical conditions. A comparison with general population mortality. Br. J. Psychiatry 130 (1977), 162–166.
45. UN, Changing Levels and Trends in Mortality: The Role of Patterns of Death by Cause. 2012, United Nations, Department of Economic and Social Affairs, Population Division.
46. Wolkowitz, O.M., Jeste, D.V., Martin, A.S., et al. Leukocyte telomere length: effects of schizophrenia, age, and gender. J. Psychiatr. Res. 85 (2017), 42–48.